Hiramatsu, Yasushi
Urata, Shingo
Ishikawa, Takayuki
Yamauchi, Takahiro
Funding for this research was provided by:
Servier
Article History
Received: 14 November 2025
Revised: 23 January 2026
Accepted: 25 January 2026
First Online: 3 March 2026
Declarations
:
: Yasushi Hiramatsu: payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Nihon Servier. Shingo Urata: support for attending meetings and/or travel, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Nihon Servier. Takayuki Ishikawa: no conflicts of interest to declare. Takahiro Yamauchi: grants or contracts from Servier; consulting fees from Servier, AbbVie, and Nippon Shinyaku; payment for expert testimonies from Otsuka Pharmaceutical and Ohara Pharmaceutical; and receipt of equipment, materials, drugs, medical writing, gifts or other services from Jazz Pharmaceuticals, Pfizer, and Nippon Kayaku.